Key result
Therapy for established venous thromboembolism during pregnancy consists of therapeutic doses of unfractionated or low-molecular-weight heparin for 4 to 6 weeks after childbirth.
This review outlines the management of VTE during pregnancy, highlighting the use of UFH or LMWH during pregnancy and the safety of warfarin postpartum.
No takes yet. Share an insight, caveat, or question.
Supports peripartum VTE management with heparins; leaves open optimal duration and alternatives for prospective trials.
Bates et al. (2002) conducted a review in Venous thromboembolism during pregnancy. Unfractionated heparin (UFH) or low-molecular-weight heparin (LMWH) was evaluated. Therapy for established venous thromboembolism during pregnancy consists of therapeutic doses of unfractionated or low-molecular-weight heparin for 4 to 6 weeks after childbirth.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: